Zymergen Inc. (ZY): Price and Financial Metrics Recent IPO
GET POWR RATINGS... FREE!
ZY Stock Price Chart Interactive Chart >
ZY Price/Volume Stats
| Current price | $44.43 | 52-week high | $52.00 |
| Prev. close | $43.67 | 52-week low | $25.75 |
| Day low | $43.23 | Volume | 1,094,900 |
| Day high | $45.30 | Avg. volume | 456,997 |
| 50-day MA | $0.00 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 4.46B |
Zymergen Inc. (ZY) Company Bio
Zymergen Inc. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. Zymergen's platform is used to discover novel molecules used to enable unique material properties. The company was incorporated in 2013 and is based in Emeryville, California.
Latest ZY News From Around the Web
Below are the latest news stories about Zymergen Inc that investors may wish to consider to help them evaluate ZY as an investment opportunity.
Zymergen to Present at Goldman Sachs Annual Global Healthcare ConferenceEMERYVILLE, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen today announced the company will be participating in the upcoming Goldman Sachs Annual Global Healthcare Virtual Conference. Zymergen’s management is scheduled to present on Wednesday, June 9th at 5:30 p.m. Eastern Time/2:30 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.zymergen.com/. About |
7 Best Tech Stocks Pumped Out by Softbank’s ‘Golden Egg’ MachineTech stocks are on display in Softbank's Vision Fund. |
Zymergen, Inc. (ZY) CEO Josh Hoffman on Q1 2021 Results - Earnings Call TranscriptZymergen, Inc. (ZY) Q1 2021 Earnings Conference Call May 24, 2021, 16:30 PM ET Company Participants Niraj Javeri - IR Josh Hoffman - Co-Founder and Chief Executive Officer Enakshi Singh - Chief Financial Officer. Conference Call Participants Doug Schenkel - Cowen Tycho Peterson - JP Morgan Matt Sykes - Goldman... |
Zymergen EPS misses by $5.26, beats on revenueZymergen (ZY): Q1 GAAP EPS of -$6.51 misses by $5.26.Revenue of $3.74M (+26.8% Y/Y) beats by $0.82M.Press Release... |
Zymergen to Report First Quarter 2021 Financial Results on May 24, 2021EMERYVILLE, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 24th, 2021. The company’s management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. A webcast of the conference call can be accessed at https://investors.zymergen.com/. The webcast will be archived and available for replay for at least 90 days after the event. About Zymergen Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of indus... |
ZY Price Returns
| 1-mo | 22.87% |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Loading social stream, please wait...